July 1, 2020
Otsuka Pharmaceutical and Axcelead Drug Discovery Partners said on June 29 that the companies have kickstarted joint drug discovery research in the CNS field, by using the startup’s proprietary Axcelead Hit-identified Target (A-HiT) project. Axcelead, which was spun off from...read more